XML 65 R94.htm IDEA: XBRL DOCUMENT v2.4.1.9
Disposition Of Pharmaceutical Product Lines And Restructuring (Details) (USD $)
12 Months Ended 1 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Jan. 31, 2009
Dec. 31, 2008
Dec. 31, 2014
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items]                
Proceeds from disposition of pharmaceutical product lines $ 3,500,000us-gaap_ProceedsFromSaleOfOtherProductiveAssets $ 3,000,000us-gaap_ProceedsFromSaleOfOtherProductiveAssets            
Acarexx And SURPASS Products And Feline Insulin Product Under Development [Member]                
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items]                
Proceeds from disposition of pharmaceutical product lines     1,400,000us-gaap_ProceedsFromSaleOfOtherProductiveAssets
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_AcarexxAndSurpassProductsAndFelineInsulinProductUnderDevelopmentMember
7,000,000us-gaap_ProceedsFromSaleOfOtherProductiveAssets
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_AcarexxAndSurpassProductsAndFelineInsulinProductUnderDevelopmentMember
       
Royalty Bearing License Agreement [Member]                
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items]                
Proceeds from disposition of pharmaceutical product lines       300,000us-gaap_ProceedsFromSaleOfOtherProductiveAssets
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_RoyaltyBearingLicenseAgreementMember
       
Milestone payment earned 300,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_RoyaltyBearingLicenseAgreementMember
      1,600,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_RoyaltyBearingLicenseAgreementMember
300,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_RoyaltyBearingLicenseAgreementMember
   
Feline Insulin Product [Member]                
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items]                
Milestone payment earned   3,500,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_FelineInsulinProductMember
      3,000,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_FelineInsulinProductMember
2,000,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_FelineInsulinProductMember
3,000,000us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_FelineInsulinProductMember
Feline Insulin Product Total Potential Milestone Payments [Member]                
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items]                
Potential milestone payments       $ 11,500,000us-gaap_GainContingencyUnrecordedAmount
/ idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis
= idxx_FelineInsulinProductTotalPotentialMilestonePaymentsMember